3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Social Adjustment: new trials by email Literature Review of Social Adjustment trials Research Report on Social Adjustment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Arbaclofen in Children and Adolescents With ASD Arbaclofen, Placebo - Autism Spectrum Disorder | Phase 2 | Completed | Celso Arango, MD, PhD | 124 | 2019-09-19 | 2023-02-08 |
| Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate Treatment Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega], Paliperidone Palmitate 546 MG Intramuscular Suspension, Extended Release [INVEGA TRINZA] - Schizophrenics | Phase 1 / Phase 2 | Completed | Calo Psychiatric Center | 72 | 2015-01-01 | 2021-02-15 |
| Clinical Trial of the "Living Well With Hearing Loss Workshop" The Living Well with Hearing Loss Workshop, hearing aid services - Hearing Loss, Stress | Phase 2 | Completed | US Department of Veterans Affairs | 135 | 2007-05-01 | 2014-03-06 |
Autism Spectrum Disorder (1) · Hearing Loss (1)
Behavior (3) · Social Behavior (3) · Child Development Disorders, Pervasive (1) · Ear Diseases (1) · Hearing Disorders (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurodevelopmental Disorders (1) · Neurologic Manifestations (1) · Otorhinolaryngologic Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Sensation Disorders (1) · Signs and Symptoms (1)
Butyric Acid (1) · Paliperidone Palmitate (1) · arbaclofen placarbil (1)
Calo Psychiatric Center (1) · Celso Arango, MD, PhD (1) · US Department of Veterans Affairs (1)
France (1) · Spain (1) · United Kingdom (1) · United States (1)
Andre Strydom, Prof. (1) · Celso Arango, Prof. (1) · For-Wey Lung, MD, ScD (1) · Jeremy Parr, Prof. (1) · Mallika Punukollu, Dr. (1) · Mara Parellada, Prof. (1) · Mitchel B Turbin (1) · Richard Delorme, Prof. (1) · Rosa Calvo, Dr. (1)
2018 (1)